Related Funds
Fund Name | Location |
CITRIS Foundry | Berkeley, California, United States |
Columbia Pacific Advisors | Seattle, United States, Washington |
Constellation Real Technologies | Colorado, Englewood, United States |
CV Catalyst Fund | New York, New York, United States |
EGS Healthcare Capital Partners | Connecticut, Norwalk, United States |
Feimalv | China, Fujian, Hunan |
Nascent Ventures | England, London, United Kingdom |
Ningbo Meishan Baoshui Gangqu Tongli Zhicheng Touzi | China, Ningbo Shi, Zhejiang |
Ningbo Shuanglin Auto Parts | China, Qingpu District |
Osisko Gold Royalties | Canada, Montreal, Quebec |
Paulson & Co. | New York, New York, United States |
Phenomenelle Angels | Madison, United States, Wisconsin |
Quadriplay Venture | France, Ile-de-France, Paris |
RESOLUTE Partners | Connecticut, Southington, United States |
S.A.C Capital Associates | New York, New York, United States |
Shanghai Securities | China, Shanghai |
Shanghai Tangsheng Investment Development | China, Shanghai |
Sirius Venture Partners | Germany, Hessen, Wiesbaden |
TIM #WCAP | Italy, Lazio, Rome |
Xingzao Finance | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
BIOMINDA BIOLOGICAL TECHNOLOGY CO., LTD | $1M | 24 Apr 2017 | Xuanwu District, Jiangsu, China | ||
$1M | 01 Nov 2015 | Shanghai, China | |||
$2M | 17 Aug 2015 | China, Jiangsu | |||
$3M | 01 Aug 2015 | China, Shanghai | |||
Kaozheng Bao | $1M | 19 Jun 2015 | Shanghai, China | ||
Kaka Wanpai | $309K | 18 Jun 2015 | Haidian, Beijing, China | ||
$463K | 29 Apr 2015 | China, Jiangsu | |||
Che Zhiliao | $2M | 12 Feb 2015 | Shanghai, China | ||
Miliyo | $463K | 24 Nov 2014 | Minhang District, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
BIOMINDA BIOLOGICAL TECHNOLOGY CO., LTD | $1M | 24 Apr 2017 | Xuanwu District, Jiangsu, China | ||
$1M | 01 Nov 2015 | Shanghai, China | |||
$2M | 17 Aug 2015 | China, Jiangsu | |||
$3M | 01 Aug 2015 | China, Shanghai | |||
Kaozheng Bao | $1M | 19 Jun 2015 | Shanghai, China | ||
Kaka Wanpai | $309K | 18 Jun 2015 | Haidian, Beijing, China | ||
$463K | 29 Apr 2015 | China, Jiangsu | |||
Che Zhiliao | $2M | 12 Feb 2015 | Shanghai, China | ||
Miliyo | $463K | 24 Nov 2014 | Minhang District, China |